Facebook Launches Search Engine AI Tool That Could Make Meta $10 Billion A Year, Analyst Says
The new feature positions Meta as a more direct competitor of Google’s search engine.
Investing
Australian billionaires’ Sigma Healthcare in talks to buy U.K.’s Boots in deal valued at $10 billion
Sigma Healthcare—which counts Australian billionaire brothers Jack and Sam Gance and their business partner Mario Verrochi as its biggest shareholders—has been seeking to expand in the U.K.
Australians invent world-class climate tech. So why aren’t we buying it?
Opinion: Australia has no shortage of climate innovation. What it lacks are enough businesses willing to buy it, argues Asha Kayla, forcing many businesses to look overseas.
Investor demand for SpaceX IPO tops $250 billion, reports
The $75 billion SpaceX seeks to raise in its historic IPO would value the company at roughly $1.77 trillion.
Does AI make us more productive at work? Yes, but there’s a catch.
Opinion: Introducing AI in your workplace will not magically lift productivity, argues Lucio Ribeiro. For that to happen, we need to make some changes to how we work.
Should Aussie startups move overseas? That’s the wrong question to ask.
The best startup founders aren’t asking whether to stay in Australia or leave, argues David Burt.
OpenAI says it filed paperwork to go public
OpenAI said it has not decided exactly when the IPO would take place.
SpaceX targets $75 billion for IPO—valuing company above US$1.75 trillion
The company plans to sell about 555.6 million shares for $135 in the initial public offering.
‘I’m now broke’: Meet the investors who lost billions buying Trump stocks and crypto
Desperate to rebuild his fortune, Donald Trump asked his political supporters to become his business partners. Those who trusted him most got hurt the worst.
‘Nothing ever like this before’: Daniela Amodei on Anthropic, Mythos and the IPO
Exclusive: In the lead-up to its IPO, Anthropic President and co-founder Daniela Amodei talks to Forbes Australia about containing its new model, Mythos, and why the frontier lab is anchoring in Australia.